A citation-based method for searching scientific literature

Thomas J Richards, Naftali Kaminski, Fred Baribaud, Susan Flavin, Carrie Brodmerkel, Daniel Horowitz, Katherine Li, Jiin Choi, Louis J Vuga, Kathleen O Lindell, Melinda Klesen, Yingze Zhang, Kevin F Gibson. Am J Respir Crit Care Med 2012
Times Cited: 237







List of co-cited articles
907 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
46

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Ivan O Rosas, Thomas J Richards, Kazuhisa Konishi, Yingze Zhang, Kevin Gibson, Anna E Lokshin, Kathleen O Lindell, Jose Cisneros, Sandra D Macdonald, Annie Pardo,[...]. PLoS Med 2008
334
45

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
35

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
31

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
R Gisli Jenkins, Juliet K Simpson, Gauri Saini, Jane H Bentley, Anne-Marie Russell, Rebecca Braybrooke, Philip L Molyneaux, Tricia M McKeever, Athol U Wells, Aiden Flynn,[...]. Lancet Respir Med 2015
166
28

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
259
28

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
Antje Prasse, Corinna Probst, Elena Bargagli, Gernot Zissel, Galen B Toews, Kevin R Flaherty, Manfred Olschewski, Paola Rottoli, Joachim Müller-Quernheim. Am J Respir Crit Care Med 2009
206
26

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
296
22

Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Jin Woo Song, Kyung Hyun Do, Se Jin Jang, Thomas V Colby, Seungbong Han, Dong Soon Kim. Chest 2013
79
27

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
587
21

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
835
21

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.
Jose D Herazo-Maya, Imre Noth, Steven R Duncan, Sunghwan Kim, Shwu-Fan Ma, George C Tseng, Eleanor Feingold, Brenda M Juan-Guardela, Thomas J Richards, Yves Lussier,[...]. Sci Transl Med 2013
151
20

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.
Jose D Herazo-Maya, Jiehuan Sun, Philip L Molyneaux, Qin Li, Julian A Villalba, Argyrios Tzouvelekis, Heather Lynn, Brenda M Juan-Guardela, Cristobal Risquez, Juan C Osorio,[...]. Lancet Respir Med 2017
45
44

Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Argyris Tzouvelekis, Jose D Herazo-Maya, Martin Slade, Jen-Hwa Chu, Giuseppe Deiuliis, Changwan Ryu, Qin Li, Koji Sakamoto, Gabriel Ibarra, Hongyi Pan,[...]. Respirology 2017
44
40

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
Toby M Maher, Eunice Oballa, Juliet K Simpson, Joanne Porte, Anthony Habgood, William A Fahy, Aiden Flynn, Philip L Molyneaux, Rebecca Braybrooke, Hrushikesh Divyateja,[...]. Lancet Respir Med 2017
82
21

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
Tasha E Fingerlin, Elissa Murphy, Weiming Zhang, Anna L Peljto, Kevin K Brown, Mark P Steele, James E Loyd, Gregory P Cosgrove, David Lynch, Steve Groshong,[...]. Nat Genet 2013
403
17

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
565
17

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
996
17

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
912
16

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
Louis J Vuga, John R Tedrow, Kusum V Pandit, Jiangning Tan, Daniel J Kass, Jianmin Xue, Divay Chandra, Joseph K Leader, Kevin F Gibson, Naftali Kaminski,[...]. Am J Respir Crit Care Med 2014
89
17

Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
Eric S White, Meng Xia, Susan Murray, Rachel Dyal, Candace M Flaherty, Kevin R Flaherty, Bethany B Moore, Ling Cheng, Tracy J Doyle, Julian Villalba,[...]. Am J Respir Crit Care Med 2016
80
20

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.
Fengrong Zuo, Naftali Kaminski, Elsie Eugui, John Allard, Zohar Yakhini, Amir Ben-Dor, Lance Lollini, David Morris, Yong Kim, Barbara DeLustro,[...]. Proc Natl Acad Sci U S A 2002
435
16

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
151
15

Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
Daryle J DePianto, Sanjay Chandriani, Alexander R Abbas, Guiquan Jia, Elsa N N'Diaye, Patrick Caplazi, Steven E Kauder, Sabyasachi Biswas, Satyajit K Karnik, Connie Ha,[...]. Thorax 2015
116
15

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
K E Greene, T E King, Y Kuroki, B Bucher-Bartelson, G W Hunninghake, L S Newman, H Nagae, R J Mason. Eur Respir J 2002
217
15

Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
Bridget D Stuart, Joyce S Lee, Julia Kozlitina, Imre Noth, Megan S Devine, Craig S Glazer, Fernando Torres, Vaidehi Kaza, Carlos E Girod, Kirk D Jones,[...]. Lancet Respir Med 2014
142
15

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Nicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, Henk J T Ruven, Adrian Kruit, Michiel Heron, Jules M M van den Bosch, Jan C Grutters. Respir Med 2011
76
19

Molecular biomarkers in idiopathic pulmonary fibrosis.
Brett Ley, Kevin K Brown, Harold R Collard. Am J Physiol Lung Cell Mol Physiol 2014
100
14

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.
M Okamoto, T Hoshino, Y Kitasato, Y Sakazaki, T Kawayama, K Fujimoto, K Ohshima, H Shiraishi, M Uchida, J Ono,[...]. Eur Respir J 2011
133
14

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
Rehan A Kahloon, Jianmin Xue, Arpit Bhargava, Eva Csizmadia, Leo Otterbein, Daniel J Kass, Jessica Bon, Makoto Soejima, Marc C Levesque, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2013
111
14

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
Akihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, Toshiharu Matsushima, Toru Takahashi, Masaharu Nishimura, Masashi Bando, Yukihiko Sugiyama, Yoshitaka Totani, Takeshi Ishizaki,[...]. Respirology 2006
171
14

Telomerase mutations in families with idiopathic pulmonary fibrosis.
Mary Y Armanios, Julian J-L Chen, Joy D Cogan, Jonathan K Alder, Roxann G Ingersoll, Cheryl Markin, William E Lawson, Mingyi Xie, Irma Vulto, John A Phillips,[...]. N Engl J Med 2007
791
14

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Brent W Kinder, Kevin K Brown, Francis X McCormack, Joachim H Ix, Alma Kervitsky, Marvin I Schwarz, Talmadge E King. Chest 2009
137
13

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis.
Annie Pardo, Sandra Cabrera, Mariel Maldonado, Moisés Selman. Respir Res 2016
115
13

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.
Annie Pardo, Kevin Gibson, José Cisneros, Thomas J Richards, Yinke Yang, Carina Becerril, Samueal Yousem, Iliana Herrera, Victor Ruiz, Moisés Selman,[...]. PLoS Med 2005
310
13

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
Antje Moeller, Sarah E Gilpin, Kjetil Ask, Gerard Cox, Deborah Cook, Jack Gauldie, Peter J Margetts, Laszlo Farkas, Julian Dobranowski, Colm Boylan,[...]. Am J Respir Crit Care Med 2009
344
13

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
824
12

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
12

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.
Jason W Chien, Thomas J Richards, Kevin F Gibson, Yingze Zhang, Kathleen O Lindell, Lixin Shao, Susan K Lyman, Joanne I Adamkewicz, Victoria Smith, Naftali Kaminski,[...]. Eur Respir J 2014
82
14


Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.
Margaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, X Rebecca Sheng, Gaik W Tew, Chunyan Gu, Guiquan Jia, Kun Peng, Jill M Ray, Brett Ley,[...]. Lancet Respir Med 2018
48
25

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
T E King, J A Tooze, M I Schwarz, K R Brown, R M Cherniack. Am J Respir Crit Care Med 2001
578
11

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
11

Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
Payal K Naik, Paul D Bozyk, J Kelley Bentley, Antonia P Popova, Carolyn M Birch, Carol A Wilke, Christopher D Fry, Eric S White, Thomas H Sisson, Nabihah Tayob,[...]. Am J Physiol Lung Cell Mol Physiol 2012
154
11

Short telomeres are a risk factor for idiopathic pulmonary fibrosis.
Jonathan K Alder, Julian J-L Chen, Lisa Lancaster, Sonye Danoff, Shu-chih Su, Joy D Cogan, Irma Vulto, Mingyi Xie, Xiaodong Qi, Rubin M Tuder,[...]. Proc Natl Acad Sci U S A 2008
454
11

MUC5B promoter polymorphism and interstitial lung abnormalities.
Gary M Hunninghake, Hiroto Hatabu, Yuka Okajima, Wei Gao, Josée Dupuis, Jeanne C Latourelle, Mizuki Nishino, Tetsuro Araki, Oscar E Zazueta, Sila Kurugol,[...]. N Engl J Med 2013
222
11

MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.
Yasmina Bauer, Eric S White, Simon de Bernard, Peter Cornelisse, Isabelle Leconte, Adele Morganti, Sebastien Roux, Oliver Nayler. ERJ Open Res 2017
40
27

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
382
11

CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.
Syed R Gilani, Louis J Vuga, Kathleen O Lindell, Kevin F Gibson, Jianmin Xue, Naftali Kaminski, Vincent G Valentine, Emily K Lindsay, M Patricia George, Chad Steele,[...]. PLoS One 2010
124
10

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Phillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, Patrick Mallia, Kirsty E Russell, Anne-Marie Russell, Elissa Murphy, Sebastian L Johnston, David A Schwartz, Athol U Wells,[...]. Am J Respir Crit Care Med 2014
266
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.